Reduction in the structural changes of experimental osteoarthritis by a nitric oxide inhibitor

Osteoarthritis and Cartilage

Volumn 7, Issue 4, 1999, Pages 416-418

  Pelletier, J P ^a   Jovanovic, D ^a   Fernandes, J C ^a   Manning, P ^b   Connor, J R ^b   Currie, M G ^b   Martel Pelletier, J ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MONSANTO COMPANY   (United States)

Author keywords

iNOS; L NIL; Osteoarthritis; Structural changes

Indexed keywords

LYSINE DERIVATIVE; N IMINOETHYLLYSINE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT; CONFERENCE PAPER; CONTROLLED STUDY; DOG; DOSE RESPONSE; HISTOLOGY; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; STAB WOUND;

EID: 0033166769     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.1998.0229     Document Type: Conference Paper

References (11)

1. Evans CH, Stefanovic-Racic M, Lancaster J. Nitric oxide and its role in orthopaedic disease. Clin Orthop 1995;312:275-94.
2. Clancy RM, Amin AR, Abramson SB. The role of nitric oxide in inflammation and immunity. Arthritis Rheum 1998;41:1141-51.
3. Järvinen TAH, Moilanen T, Järvinen TLN, Moilanen E. Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage. Mediators of Inflammation 1995;4:107-11.
4. Murrell GAC, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995;206:15-21.
5. Farrell AJ, Blake DR, Palmer RM, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219-22.
6. Amin AR, Di Cesare PE, Vyas P, Attur MG, Tzeng E, Billiar TR, et al. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: Evidence for an inducible neuronal-like nitric oxide synthase. J Exp Med 1995;182: 2097-102.
7. Pelletier JP, Jovanovic D, Fernandes JC, Manning PT, Connor JR, Currie MG, et al. Reduced progression of experimental osteoarthritis in-vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 1998;41:1275-86.
8. Pelletier JP, Di Battista JA, Raynauld JP, Wilhelm S, Martel-Pelletier J. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1 and oncogene protein synthesis in experimental osteoarthritis. Lab Invest 1995;72:578-86.
9. Pelletier JP, Mineau F, Raynauld JP, Woessner JF Jr, Gunja-Smith Z, Martel-Pelletier J. Intraarticular injections with methylprednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis. Arthritis Rheum 1994;37:414-23.
10. Fernandes JC, Martel-Pelletier J, Otterness IG, Lopez-Anaya A, Mineau F, Tardif G, et al. Effects of tenidap on canine experimental osteoarthritis: I. Morphologic and metalloprotease analysis. Arthritis Rheum 1995;38:1290-1303.
11. Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1971;53:523-37.